MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0017567
Noksira Pharma Private Limited
Noksira Pharma Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.33 Lakh
▼ 92% YoY
Net profit · FY 2025
₹15,000
Net margin 4.5%
EBITDA · FY 2025
₹1.35 Lakh
EBITDA margin 40.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Noksira Pharma Private Limited
Data last updated:
Noksira Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 23 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2012PTC240740. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Barun Kumar Singh and Dinesh Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 207 Harsha House Commercial Complex Karam Pura Near Milan Cinema, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.33 Lakh, a decline of 92% compared to the previous year. For the same year it recorded a net profit of ₹15,000 (net margin 4.5%) and EBITDA of ₹1.35 Lakh (EBITDA margin 40.5%). Revenue has declined at a compounded annual rate (CAGR) of 62% over three years and 53% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
Noksira Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0017567). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24297DL2012PTC240740
Registration Number 240740
Incorporation Date 23 August 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0017567
Recognitions & Rankings of Noksira Pharma
Contact details
Noksira Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address207 Harsha House Commercial Complex Karam Pura Near Milan Cinema, New Delhi, Delhi, India – 110015
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Noksira Pharma Private Limited, buy the company report.
Comprehensive company report
Noksira Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Noksira Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Noksira Pharma Private Limited, buy the company report.
Financials of Noksira Pharma Private Limited
FY 2025 filings availableNoksira Pharma Private Limited reported revenue of ₹3.33 Lakh (down 92% YoY) for FY 2025.
Revenue · FY 2025
₹3.33 Lakh ▼ 92%
Net profit · FY 2025
₹15,000 margin 4.5%
EBITDA · FY 2025
₹1.35 Lakh margin 40.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 92%
3 years · compounded
▼ 62%
5 years · compounded
▼ 53%
EBITDA CAGR growth
1 year
▼ 25%
3 years · compounded
▲ 31%
5 years · compounded
▼ 8%
Revenue has declined at a compounded annual rate (CAGR) of 53% over five years, including a 92% fall in the latest year. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 40.5% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noksira Pharma Private Limited, buy the company report.
Board of directors of Noksira Pharma Private Limited
Noksira Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Barun Kumar Singh Also directs: Ariskon Pharma Private Limited | Director | 23 Aug 2012 | 14 Years 2 Months | Current |
| Dinesh Kumar Singh Also directs: Ariskon Pharma Private Limited, JC Lifecare Private Limited | Director | 23 Aug 2012 | 14 Years 2 Months | Current |
Peer comparison
Noksira Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maamaya Devi Agro Products Private Limited | ₹3.33 Lakh (FY 2025) | 13.0% | Bankura, West Bengal, India | |||
| Super Power Filter Private Limited | ₹3.33 Lakh (FY 2024) | -53.0% | Bhilwara, Rajasthan, India | |||
| Lalthangzai Industries Private Limited | ₹3.33 Lakh (FY 2022) | Lunglei, Mizoram, India | ||||
| Virtual Commercial Pvt Ltd | ₹3.33 Lakh (FY 2019) | -86.0% | Kolkata, West Bengal, India | |||
| Delight Dreams Products & Services Private Limited | ₹3.33 Lakh (FY 2023) | -51.0% | Nagpur, Maharashtra, India | |||
| Noksira Pharma Private Limitedthis company | ₹3.33 Lakh (FY 2025) | ₹15,000 | 4.5% | -92.0% | New Delhi, Delhi, India | |
| Aristro Business Private Limited | ₹3.33 Lakh (FY 2025) | -99.0% | Kalyani, West Bengal, India | |||
| Resper International (India) Private Limited | ₹3.33 Lakh (FY 2021) | -76.0% | Dharavi, Mumbai, Maharashtra, India | |||
| Srimath Consumer Merchandise Private Limited | ₹3.33 Lakh (FY 2018) | Hyderabad, Telangana, India | ||||
| VDP Markventures Private Limited | ₹3.33 Lakh (FY 2024) | 5.0% | Pune, Maharashtra, India | |||
| Bhootnath Agro Producer Company Limited | ₹3.33 Lakh (FY 2024) | -16.0% | Parbhani, Maharashtra, India |
To see the full peer comparison of Noksira Pharma Private Limited, buy the company report.
Auditor
Noksira Pharma Private Limited is audited by AWDHESH KUMAR SINGH for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AWDHESH KUMAR SINGH | FY 2017 | 513423 |
Shareholding
The shareholding of Noksira Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Noksira Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2020 | 100345647 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Noksira Pharma Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rohtak, Haryana | Cheque dishonour complaint | Filed against the company by M/S Truworth Healthcare | Pending |
| District court, New Delhi, Delhi | Criminal case | Filed against the company by an individual | Disposed |
| District court, West, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
To see the full case history of Noksira Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noksira Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Noksira Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Noksira Pharma Private Limited, buy the company report.
Recent activity
Noksira Pharma Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Ram Narayan Pathak ceased to be Additional Director on 07 Dec 2016.
AGM
Noksira Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Noksira Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100345647 was registered on 30 May 2020.
Ceased
Ram Narayan Pathak ceased to be Additional Director.
Ceased
Rana Amrendra Kumar Deepak ceased to be Director.
Appointed
Barun Kumar Singh was appointed as Director.
Appointed
Dinesh Kumar Singh was appointed as Director.
Incorporation
23 Aug 2012
Noksira Pharma Private Limited was registered on 23 Aug 2012 with Roc Delhi Ii & aged 14 years 2 months as per MCA records.
Frequently asked questions
Noksira Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 23 August 2012 (14+ years old) and is registered under CIN U24297DL2012PTC240740.
Noksira Pharma has 2 current directors:
- Barun Kumar Singh - Director
- Dinesh Kumar Singh - Director
The latest financial statements of Noksira Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Noksira Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Noksira Pharma is U24297DL2012PTC240740. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noksira Pharma has 3 court cases on record: 3 filed against it. 1 is pending.
Noksira Pharma was incorporated on 23 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Noksira Pharma by revenue are Maamaya Devi Agro Products Private Limited, Super Power Filter Private Limited, Lalthangzai Industries Private Limited, Virtual Commercial Pvt Ltd, Delight Dreams Products & Services Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Ram Narayan Pathak ceased to be Additional Director on 07 Dec 2016. Rana Amrendra Kumar Deepak ceased to be Director on 30 Nov 2016. Barun Kumar Singh was appointed as Director on 23 Aug 2012. Noksira Pharma has 4 board changes on record in total.
Yes, Noksira Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0017567).
The registered office of Noksira Pharma is at 207 Harsha House Commercial Complex Karam Pura Near Milan Cinema, New Delhi, Delhi, India – 110015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages